EUR-1008 (APT-1008)
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for EUR-1008 (APT-1008), covering 2014-03-12 to 2014-04-04. Get the full timeline:
Most recent: Clinical Trial Update: Study to Evaluate the Safety and Efficacy of EUR-1008 (APT-1008) Pancreatic Enzyme Product in Participants With Cystic Fibrosis and Exocrine Pancreatic Insufficiency [Phase 3]